This study tested a hypothesis that primary human vaginal cells derived from tissue of premenopausal women with severe pelvic organ prolapse (POP-HVCs) would display differential functional characteristics as compared to vaginal cells derived from asymptomatic women with normal pelvic floor support (control-HVCs).
Methods:
Vaginal tissue biopsies were collected from premenopausal patients with POP (n = 8) and asymptomatic controls (n = 7) during vaginal hysterectomy or repair. Primary vaginal cells were isolated by enzymatic digestion and characterized by immunocytochemistry. Cell attachment and proliferation on different matrices (collagen I, collagen II, collagen IV, fibronectin, laminin, tenascin, and vitronectin) were compared between POP-HVCs and control-HVCs. RNA was extracted, and the expression of 84 genes was screened using Human Extracellular Matrix and Adhesion Molecules RT2 Profiler PCR array. The expression of selected genes was verified by quantitative reverse transcription-polymerase chain reaction.
Results:
(1) Control-HVCs attached to collagen IV more efficiently than POP-HVCs; (2) control-HVCs and POP-HVCs show a similar proliferation rate when plated on proNectin and collagen I; (3) when seeded on collagen I, resting POP-HVCs expressed significantly (P < .05) increased transcript levels of collagen VII, multiple matrix metalloproteinases (MMP3, MMP7, MMP10, MMP12, MMP13, and MMP14), integrins (ITGA1, ITGA4, ITGA6, ITGA8, ITGB1, ITGB2, and ITGB3), and cell adhesion molecules as compared to control-HVCs. Collagen XV and tissue inhibitors of MMPs (TIMP1 and TIMP2) as well as genes involved in the biogenesis and maturation of collagen and elastin fibers (LOX, LOXL1-LOXL3, BMP1, and ADAMTS2) were significantly downregulated in POP-HVCs versus control-HVCs (P < .05).
Conclusions:
Resting primary POP-HVCs in vitro show altered cellular characteristics as compared to control-HVCs, which may influence their dynamic responses to external mechanical or hormonal stimuli.
BarberMDViscoAGWymanJFFantlJABumpRC. Sexual function in women with urinary incontinence and pelvic organ prolapse. Obstet Gynecol. 2002;99(2):281–289.
2.
HeitMRosenquistCCulliganPGrahamCMurphyMShottS. Predicting treatment choice for patients with pelvic organ prolapse. Obstet Gynecol. 2003;101(6):1279–1284.
3.
NygaardIBarberMDBurgioKL. Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 2008;300(11):1311–1316.
4.
OlsenALSmithVJBergstromJOCollingJCClarkAL. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 1997;89(4):501–506.
5.
LukaczESLawrenceJMContrerasRNagerCWLuberKM. Parity, mode of delivery, and pelvic floor disorders. Obstet Gynecol. 2006;107(6):1253–1260.
6.
MoalliPAJonesISMeynLAZyczynskiHM. Risk factors associated with pelvic floor disorders in women undergoing surgical repair. Obstet Gynecol. 2003;101(5 pt 1):869–874.
7.
BuchsbaumGMDuecyEEKerrLAHuangLSPerevichMGuzickDS. Pelvic organ prolapse in nulliparous women and their parous sisters. Obstet Gynecol. 2006;108(6):1388–1393.
8.
WhitcombELRortveitGBrownJS. Racial differences in pelvic organ prolapse. Obstet Gynecol. 2009;114(6):1271–1277.
9.
NortonPAAllen-BradyKWuJEggerMCannon-AlbrightL. Clinical characteristics of women with familial pelvic floor disorders. Int Urogynecol J. 2015;26(3):401–406.
10.
CareyMSlackMHiggsPWynn-WilliamsMCornishA. Vaginal surgery for pelvic organ prolapse using mesh and a vaginal support device. BJOG. 2008;115(3):391–397.
11.
AbedHRahnDDLowensteinLBalkEMClemonsJLRogersRG. Incidence and management of graft erosion, wound granulation, and dyspareunia following vaginal prolapse repair with graft materials: a systematic review. Int Urogynecol J. 2011;22(7):789–798.
12.
SkalaCEPetryIBGebhardS. Isolation of fibroblasts for coating of meshes for reconstructive surgery: differences between mesh types. Regen Med. 2009;4(2):197–204.
13.
ChenGSatoTOhgushiHUshidaTTateishiTTanakaJ. Culturing of skin fibroblasts in a thin PLGA-collagen hybrid mesh. Biomaterials. 2005;26(15):2559–2566.
14.
AlarabMBortoliniMADrutzHLyeSShynlovaO. LOX family enzymes expression in vaginal tissue of premenopausal women with severe pelvic organ prolapse. Int Urogynecol J. 2010;21(11):1397–1404.
15.
BortoliniMAShynlovaODrutzHP. Expression of bone morphogenetic protein-1 in vaginal tissue of women with severe pelvic organ prolapse. Am J Obstet Gynecol. 2011;204(6):544–548.
16.
ReddyKVMangaleSS. Integrin receptors: the dynamic modulators of endometrial function. Tissue Cell. 2003;35(4):260–273.
17.
Martinez-LemusLAWuXWilsonE. Integrins as unique receptors for vascular control. J Vasc Res. 2003;40(3):211–233.
18.
VermaRPHanschC. Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs. Bioorg Med Chem. 2007;15(6):2223–2268.
19.
LiangCCHuangHYTsengLHChangSDLoTSLeeCL. Expression of matrix metalloproteinase-2 and tissue inhibitors of metalloproteinase-1 (TIMP1, TIMP2 and TIMP3) in women with uterine prolapse but without urinary incontinence. Eur J Obstet Gynecol Reprod Biol. 2010;153(1):94–98.
20.
MoalliPAShandSHZyczynskiHMGordySCMeynLA. Remodeling of vaginal connective tissue in patients with prolapse. Obstet Gynecol. 2005;106(5 pt 1):953–963.
21.
PhillipsCHAnthonyFBenyonCMongaAK. Collagen metabolism in the uterosacral ligaments and vaginal skin of women with uterine prolapse. BJOG. 2006;113(1):39–46.
22.
ShynlovaOBortoliniMAAlarabM. Genes responsible for vaginal extracellular matrix metabolism are modulated by women’s reproductive cycle and menopause. Int Braz J Urol. 2013;39(2):257–267.
23.
SrikhajonKShynlovaOPreechapornprasertAChanrachakulBLyeS. A new role for monocytes in modulating myometrial inflammation during human labor. Biol Reprod. 2014;91(1):10.
24.
MedelSAlarabMKufaishiHDrutzHShynlovaO. Attachment of primary vaginal fibroblasts to absorbable and nonabsorbable implant materials coated with platelet-rich plasma: potential application in pelvic organ prolapse surgery. Female Pelvic Med Reconstr Surg. 2015;21(4):190–197.
25.
MaherCMFeinerBBaesslerKGlazenerCM. Surgical management of pelvic organ prolapse in women: the updated summary version Cochrane review. Int Urogynecol J. 2011;22:1445–1457.
26.
BoennelyckeMChristensenLNielsenLFGrasSLoseG. Fresh muscle fiber fragments on a scaffold in rats—a new concept in urogynecology?Am J Obstet Gynecol. 2011;205(3):235–234.
27.
HoMHHeydarkhanSVernetD. Stimulating vaginal repair in rats through skeletal muscle-derived stem cells seeded on small intestinal submucosal scaffolds. Obstet Gynecol. 2009;114(2 pt 1):300–309.
28.
HungMJWenMCHungCNHoESChenGDYangVC. Tissue-engineered fascia from vaginal fibroblasts for patients needing reconstructive pelvic surgery. Int Urogynecol J. 2010;21(9):1085–1093.
29.
UlrichDEdwardsSLSuK. Human endometrial mesenchymal stem cells modulate the tissue response and mechanical behavior of polyamide mesh implants for pelvic organ prolapse repair. Tissue Eng Part A. 2014;20(3-4):785–798.
30.
KawanoHKimura-KurodaJKomutaY. Role of the lesion scar in the response to damage and repair of the central nervous system. Cell Tissue Res. 2012;349(1):169–180.
31.
ChelbergMKTsilibaryECHauserARMcCarthyJB. Type IV collagen-mediated melanoma cell adhesion and migration: involvement of multiple, distinct domains of the collagen molecule. Cancer Res. 1989;49(17):4796–4802.
32.
AlarabMKufaishiHLyeSDrutzHShynlovaO. Expression of extracellular matrix-remodeling proteins is altered in vaginal tissue of premenopausal women with severe pelvic organ prolapse. Reprod Sci. 2014;21(6):704–715.
33.
ChenBHWenYLiHPolanML. Collagen metabolism and turnover in women with stress urinary incontinence and pelvic prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2002;13(2):80–87.
34.
KannanKMcConnellAMcLeodMRaneA. Microscopic alterations of vaginal tissue in women with pelvic organ prolapse. J Obstet Gynaecol. 2011;31(3):250–253.
35.
MakinenJKahariVMSoderstromKOVuorioEHirvonenT. Collagen synthesis in the vaginal connective tissue of patients with and without uterine prolapse. Eur J Obstet Gynecol Reprod Biol. 1987;24(4):319–325.
36.
KerkhofMHRuiz-ZapataAMBrilH. Changes in tissue composition of the vaginal wall of premenopausal women with prolapse. Am J Obstet Gynecol. 2014;210(2):168–169.
37.
MuonaAEklundLVaisanenTPihlajaniemiT. Developmentally regulated expression of type XV collagen correlates with abnormalities in Col15a1(-/-) mice. Matrix Biol. 2002;21(1):89–102.
38.
NishieWNatsugaKNakamuraH. A recurrent ‘hot spot’ glycine substitution mutation, G2043 R in COL7A1, induces dominant dystrophic epidermolysis bullosa associated with intracytoplasmic accumulation of pro-collagen VII. J Dermatol Sci. 2014;75(1):69–71.
39.
GailitJPierschbacherMClarkRA. Expression of functional alpha 4 beta 1 integrin by human dermal fibroblasts. J Invest Dermatol. 1993;100(3):323–328.
40.
ValeriusMTPattersonLTFengYPotterSS. Hoxa 11 is upstream of Integrin alpha8 expression in the developing kidney. Proc Natl Acad Sci U S A. 2002;99(12):8090–8095.
41.
MaYGuessMDatarA. Knockdown of Hoxa11 in vivo in the uterosacral ligament and uterus of mice results in altered collagen and matrix metalloproteinase activity. Biol Reprod. 2012;86(4):100.
42.
BumpRCNortonPA. Epidemiology and natural history of pelvic floor dysfunction. Obstet Gynecol Clin North Am. 1998;25(4):723–746.
43.
SwiftSWoodmanPO’BoyleA. Pelvic Organ Support Study (POSST): the distribution, clinical definition, and epidemiologic condition of pelvic organ support defects. Am J Obstet Gynecol. 2005;192(3):795–806.
44.
DallenbachPKaelin-GambirasioIDubuissonJBBoulvainM. Risk factors for pelvic organ prolapse repair after hysterectomy. Obstet Gynecol. 2007;110(3):625–632.
45.
LinSYTeeYTNgSCChangHLinPChenGD. Changes in the extracellular matrix in the anterior vagina of women with or without prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2007;18(1):43–48.
46.
SalmanMCOzyuncuOSargonMFKucukaliTDurukanT. Light and electron microscopic evaluation of cardinal ligaments in women with or without uterine prolapse. Int Urogynecol J. 2010;21(12):235–239.
47.
SzauterKMCaoTBoydCDCsiszarK. Lysyl oxidase in development, aging and pathologies of the skin. Pathol Biol (Paris). 2005;53(7):448–456.
48.
LambertCAColigeACLapiereCMNusgensBV. Coordinated regulation of procollagens I and III and their post-translational enzymes by dissipation of mechanical tension in human dermal fibroblasts. Eur J Cell Biol. 2001;80(7):479–485.
49.
HowardEWCriderBJUpdikeDL. MMP-2 expression by fibroblasts is suppressed by the myofibroblast phenotype. Exp Cell Res. 2012;318(13):1542–1553.
50.
Ruiz-ZapataAMKerkhofMHZandieh-DoulabiBBrolmannHASmitTHHelderMN. Fibroblasts from women with pelvic organ prolapse show differential mechanoresponses depending on surface substrates. Int Urogynecol J. 2013;24(9):1567–1575.
51.
Ruiz-ZapataAMKerkhofMHZandieh-DoulabiBBrolmannHASmitTHHelderMN. Functional characteristics of vaginal fibroblastic cells from premenopausal women with pelvic organ prolapse. Mol Hum Reprod. 2014;20(11):1135–1143.
52.
LafleurMATesterAMThompsonEW. Selective involvement of TIMP2 in the second activational cleavage of pro-MMP-2: refinement of the pro-MMP-2 activation mechanism. FEBS Lett. 2003;553(3):457–463.
53.
GuoCPiacentiniL. Type I collagen-induced MMP-2 activation coincides with up-regulation of membrane type 1-matrix metalloproteinase and TIMP2 in cardiac fibroblasts. J Biol Chem. 2003;278(47):46699–46708.
54.
BorrirukwanitKLafleurMAMercuriFA. The type I collagen induction of MT1-MMP-mediated MMP-2 activation is repressed by alphaVbeta3 integrin in human breast cancer cells. Matrix Biol. 2007;26(4):291–305.
55.
BrooksPCStrombladSSandersLC. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell. 1996;85(5):683–693.
